Mucositis is a common complication of chemotherapy, radiotherapy and targeted agents. It
often affects compliance to anticancer therapies as it frequently causes schedule delays …

Oral Mucositis (OM) is among the most common and dreaded toxicities of cancer therapy. It
occurs in almost all patients who receive radiation therapy in which areas of oral and …

The objective of the present study was to evaluate the effect of mulberry leaf extract (ME)
fermented with Lactobacillus acidophilus A4 (A4) on intestinal mucositis induced by 5 …

Oral mucositis (OM) is an important side effect of cancer treatment, characterized by
ulcerative lesions in the mucosa of patients undergoing radiotherapy or chemotherapy …

Purpose Early inflammation is a major factor of mucosal reactions to radiotherapy.
Pentoxifylline administration resulted in a significant amelioration of radiation-induced oral …

Purpose Diarrhea and oral mucositis induced by afatinib can cause devastating quality of
life issues for patients undergoing afatinib treatment. Several studies have shown that …

Background Toxicity of the oral and gastrointestinal mucosa induced by high-dose
melphalan is a clinical challenge with no documented prophylactic interventions or …

The purpose of this study was to evaluate the association between tumor necrosis factor
(TNF)‑α polymorphisms and oral mucositis (OM) from 5‑fluorouracil (5‑FU) plus cisplatin …

Introduction: Oral mucositis is a common and worrying clinical condition in patients
undergoing radiotherapy of the head and neck regions and aggressive chemotherapy …

Objective Cancer therapy–induced inflammation of oral and gastrointestinal mucosae affects
patients nonuniformly. Preventive strategies are limited; no biomarker exists for pretreatment …